Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial

BACKGROUND: The incidence of anal cancer is rising in the last decades and more women are affected than men. The prognosis after chemoradiation is very good with complete remission rates of 80–90%. Thus, reducing therapy-related toxicities and improving quality of life are of high importance. With t...

Descripción completa

Detalles Bibliográficos
Autores principales: Arians, Nathalie, Häfner, Matthias, Krisam, Johannes, Lang, Kristin, Wark, Antje, Koerber, Stefan A., Hommertgen, Adriane, Debus, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974962/
https://www.ncbi.nlm.nih.gov/pubmed/31964381
http://dx.doi.org/10.1186/s12885-020-6547-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974962/
https://www.ncbi.nlm.nih.gov/pubmed/31964381
http://dx.doi.org/10.1186/s12885-020-6547-7

Ejemplares similares